# DaVita (DVA) — Analyst Forecast

DVA · NYSE · Stock

Canonical page: https://www.lighthorse.io/tickers/dva/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Buy | 5 | 5 | 1 | 11 |

## Price target

| Low | Average | High | Analysts |
| --- | --- | --- | --- |
| $215.00 | $219.67 | $224.00 | 3 |

Last price $189.16 (as of Oct 16, 2026).

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Aug 7, 2026 | Truist Securities | Maintained | Hold | $215.00 |
| Aug 7, 2026 | TD Cowen | Upgraded | Hold → Buy | $220.00 |
| Aug 5, 2026 | Barclays | Maintained | Equal-Weight | $224.00 |
| Jul 14, 2026 | Truist Securities | Maintained | Hold | $250.00 |
| Jul 10, 2026 | UBS | Maintained | Buy | $270.00 |
| Jul 9, 2026 | Barclays | Maintained | Equal-Weight | $218.00 |
| May 11, 2026 | TD Cowen | Maintained | Hold | $201.00 |
| May 8, 2026 | Barclays | Maintained | Equal-Weight | $194.00 |
| May 8, 2026 | Truist Securities | Maintained | Hold | $205.00 |
| May 7, 2026 | UBS | Maintained | Buy | $235.00 |
| May 6, 2026 | Deutsche Bank | Upgraded | Hold → Buy | $220.00 |
| Feb 4, 2026 | UBS | Maintained | Buy | $190.00 |
| Feb 3, 2026 | Barclays | Maintained | Equal-Weight | $158.00 |
| Nov 3, 2025 | TD Cowen | Maintained | Hold | $133.00 |
| Oct 30, 2025 | Barclays | Maintained | Equal-Weight | $143.00 |
| Oct 9, 2025 | Barclays | Maintained | Equal-Weight | $149.00 |
| Sep 10, 2025 | B of A Securities | Maintained | Underperform | $140.00 |
| Aug 7, 2025 | Barclays | Maintained | Equal-Weight | $160.00 |
| May 19, 2025 | Truist Securities | Maintained | Hold | $164.00 |
| Feb 18, 2025 | Barclays | Maintained | Equal-Weight | $169.00 |

## Frequently Asked Questions

### What is the price target for DVA stock?

The average 12-month analyst price target for DaVita (DVA) is $219.67, with a high estimate of $224.00 and a low of $215.00, across 3 analysts.

### Is DVA a buy, sell, or hold?

Analysts covering DaVita currently average a Buy rating: 5 buy, 5 hold and 1 sell, from 11 analysts. Ratings reflect analyst opinion, not investment advice.

### What upside do analysts see for DVA?

The average price target of $219.67 implies 16.13% upside from the last price of $189.16.

### What is the latest analyst rating on DVA?

On Aug 7, 2026, Truist Securities maintained DaVita at Hold with a price target of $215.00.

## Similar Stocks

- [CAH](https://www.lighthorse.io/tickers/cah) — Cardinal Health, Inc. Common Stock
- [ITGR](https://www.lighthorse.io/tickers/itgr) — Integer Holdings Corporation Common Stock
- [COR](https://www.lighthorse.io/tickers/cor) — Cencora, Inc. Common Stock
- [HQY](https://www.lighthorse.io/tickers/hqy) — HealthEquity, Inc. - Common Stock
- [MMSI](https://www.lighthorse.io/tickers/mmsi) — Merit Medical Systems, Inc. - Common Stock
- [HAE](https://www.lighthorse.io/tickers/hae) — Haemonetics Corporation Common Stock
- [MCK](https://www.lighthorse.io/tickers/mck) — McKesson Corporation Common Stock
- [EHC](https://www.lighthorse.io/tickers/ehc) — Encompass Health Corporation Common Stock
- [ALGN](https://www.lighthorse.io/tickers/algn) — Align Technology, Inc. - Common Stock
- [DXCM](https://www.lighthorse.io/tickers/dxcm) — DexCom, Inc. - Common Stock

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).